The Journal of Clinical and Translational Hepatology (JCTH) is published by Xia & He Publishing Inc. in association with the Second Affiliated Hospital of Chongqing Medical University. JCTH publishes high quality, peer reviewed studies in the translational and clinical human health sciences of liver diseases. JCTH has established high standards for publication of original research, which are characterized by a study’s novelty, quality, and ethical conduct in the scientific process as well as in the communication of the research findings. Each issue includes articles by leading authorities on topics in hepatology that are germane to the most current challenges in the field. Special features include reports on the latest advances in drug development and technology that are relevant to liver diseases. Regular features of JCTH also include editorials, correspondences and invited commentaries on rapidly progressing areas in hepatology. All articles published by JCTH, both solicited and unsolicited, must pass our rigorous peer review process.
The open access publishing model used by JCTH avails all publications to an international readership audience, prompting worldwide interest from contributing authors and helping to promote the diverse range in hepatology topics covered in our journal. JCTH welcomes submissions of articles within its topical scope, which includes:
- Novel discoveries in translational and clinical hepatology
- Liver disease mechanisms
- Novel techniques in research and management of liver diseases
- Epidemiological/environmental factors of liver diseases
- Role of immune system function in liver diseases
- Acute and chronic hepatitis
- Cirrhosis
- Genetic and metabolic liver diseases and their complications
- Hepatobiliary diseases
- Liver cancer
- Drug metabolism
Billary disease
Peritoneal tubeculosis